23/09/2022An interdisciplinary research team at the Technical University of Munich (TUM) has now developed a new algorithm that improves the quality of MR images by depicting water, fat, and silicone simultaneously in a reliable and fully automated way.
22/09/2022Breast cancer diagnosis usually includes invasive testing with tissue biopsies. The samples have to be extracted from the cancerous tissue or cells. To make the process easier on the patients, the project LIBIMEDOTS is currently developing a different approach with liquid biopsy technology.
08/09/2022In the USA, doctors recommend that couples have genetic screening before trying to conceive. Researchers at the University of Zurich have now shown that a maximal variant of this test detects the risk in 44 percent of couples who are related by blood, and in just 5 percent of other couples.
07/09/2022Heart attacks in women are more likely to be fatal than in men. The reasons are differences in age and in comorbidity burden which makes risk assessment in women a challenge. Researchers at the University of Zurich have now developed a novel artificial-intelligence-based risk score that improves personalized care for female patients with heart attacks.
29/08/2022The Stavanger-based research collaboration Safer Births has developed into the Safer Births Bundle of Care (SBBC) programme. Various methods for fetal heart rate monitoring during labour, newborn resuscitation and simulation-based learning strategies for increased newborn survival in countries where health services are limited.
07/07/2022An artificial intelligence (AI) algorithm trained to listen to patients pass urine is able to identify abnormal flows and could be a useful and cost-effective means of monitoring and managing urology patients at home.
05/07/2022If breast cancer is suspected, doctors carry out a biopsy. However, this is invasive, painful and costly. It also takes several days to get the results. In the future, diagnosis could be made via a liquid biopsy of a patient’s blood — a gentle, cost-effective method that would deliver the results within just a few hours.
04/07/2022Contrast-enhanced mammography (CEM) may be a useful alternative test for neoadjuvant therapy (NAT) response assessment in patients with breast cancer who are unable to undergo MRI.